Back

Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study

27 August 2017 (14:00 - 14:15)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session Thrombosis Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Laila Staerk

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

3 More presentations in this session

Presentation thumbnail
Impact on clinical outcome of on-treatment platelet reactivity according to concordant platelet function tests: the multi-test platelet function study
Doctor P. Guedeney (Paris, FR)
Abstract Slides Video
Presentation thumbnail
A meta-analysis of INR targets for mechanical heart valves: we need new evidence
Doctor S. Gupta (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Thrombin Exosite 1 Inhibition with JNJ-375 Inhibits Fibrin-Rich Thrombus Formation in a Human Translational Model of Thrombosis
Doctor S. Wilson (Edinburgh, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session Thrombosis

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources